Comments on: New Weight Loss Drug Shows Promise http://www.weightlosssurgerychannel.com/breaking-wls-news/new-weight-loss-drug-shows-promise.html/ Information and Support for Pre- and Post-Op Weight Loss Surgery Patients Sat, 31 Dec 2011 17:32:56 +0000 hourly 1 http://wordpress.org/?v=3.2.1 By: Richard Ho http://www.weightlosssurgerychannel.com/breaking-wls-news/new-weight-loss-drug-shows-promise.html/comment-page-1/#comment-3788 Richard Ho Mon, 12 Jul 2010 13:10:58 +0000 http://www.weightlosssurgerychannel.com/breaking-wls-news/new-weight-loss-drug-shows-promise.html/#comment-3788 Weigh loss drug is meant to take continuously or indefinitely for weight control. A recent FDA spokeperson has made that point, thus averse side effects must be ruled out. I think Lorcaserin has shown clearly to have achieved that goal coupled with weight loss within the FDA guideline. This is a novel drug developed with a large subjects in trials, so I think we have finally come up with a new drug for the weight management industry. Eisai has the leg up over all the other large drug companies to ink this contract. Weigh loss drug is meant to take continuously or indefinitely for weight control. A recent FDA spokeperson has made that point, thus averse side effects must be ruled out. I think Lorcaserin has shown clearly to have achieved that goal coupled with weight loss within the FDA guideline. This is a novel drug developed with a large subjects in trials, so I think we have finally come up with a new drug for the weight management industry. Eisai has the leg up over all the other large drug companies to ink this contract.

]]> By: Steve H http://www.weightlosssurgerychannel.com/breaking-wls-news/new-weight-loss-drug-shows-promise.html/comment-page-1/#comment-3787 Steve H Mon, 12 Jul 2010 12:37:43 +0000 http://www.weightlosssurgerychannel.com/breaking-wls-news/new-weight-loss-drug-shows-promise.html/#comment-3787 I have been following the development of Lorcaserin for close to two years through their trial periods. Each trial phase meets and exceeds the FDA guidlines for weight loss drug candidates. Lorcaserin also has shown clinical test results favorable to Type II diabetes patients enrolled in the study, with the test data specific to Type II to be released shortly. When approved, it potentially can be a part of a doctor's front line combined therapy treatment for overweight Type II diabetes patients. In my opinion this new compound will pass the FDA and be approved. Of the three weight loss drugs pending FDA approval, Arena's (ARNA) Lorcaserin presents the highest saftey levels. It should become the first choice for doctor's, investors, and patients. I have been following the development of Lorcaserin for close to two years through their trial periods. Each trial phase meets and exceeds the FDA guidlines for weight loss drug candidates. Lorcaserin also has shown clinical test results favorable to Type II diabetes patients enrolled in the study, with the test data specific to Type II to be released shortly. When approved, it potentially can be a part of a doctor’s front line combined therapy treatment for overweight Type II diabetes patients.

In my opinion this new compound will pass the FDA and be approved. Of the three weight loss drugs pending FDA approval, Arena’s (ARNA) Lorcaserin presents the highest saftey levels. It should become the first choice for doctor’s, investors, and patients.

]]>